FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for Benztropine Mesylate submitted by ScieGen Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrapyramidal Symptoms
• Parkinson Disease

Drugs mentioned

• Benztropine Mesylate (benztropine mesylate)

Snippet

SUPPL AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)